Gary Hsich, MD

216.636.5860

Gary Hsich, MD

Appointed: 2005

Gary Hsich, MD
Department: Center for Pediatric Neurology
Location: Cleveland Clinic Main Campus
Mail Code S60
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.636.5860
WorkFax:216.445.9139
Gary Hsich, MD
Department: Center for Pediatric Neurology
Location: Hillcrest Hospital
Mail Code S60
6770 Mayfield Road
Mayfield Heights, OH 44124
WorkAppointment:216.636.5860
WorkFax:216.445.9139
Gary Hsich, MD
Department: Neurology
Location: Cleveland Clinic Main Campus
Mail Code S60
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.636.5860
WorkFax:216.445.9139
Surgeon:
No
Treats:
Children & Adolescents Only

Professional Highlights

  • Howard Hughes Medical Institutes Postdoctoral Fellowship.

Education & Fellowships

Fellowship - Massachusetts General Hospital
Neurology Research Gene Therapy
Boston, MA USA
2004
Residency - Children's Hospital of Boston
Child Neurology
Boston, MA USA
1999
Residency - Children's Hospital of Philadelphia
Pediatrics
Philadelphia, PA USA
1998
Internship - Children's Hospital of Philadelphia
Pediatrics
Philadelphia, PA USA
1997
Medical School - Johns Hopkins University School of Medicine
Baltimore, MD USA
1996
Undergraduate - The John Hopkins University
Baltimore, MD USA
1991

Certifications

  • Neurology with Special Qualifications in Child Neurology

Specialty Interests

leukodystrophies, lysosomal storage disorders, Pediatric Neurology Child abuse Factitious disorders

Additional Training

  • Fellowship: Kennedy-Krieger Institute, Baltimore, Md.

Innovations & Patents

Patent Number 5,998,149.  Issued December 7, 1999.  Inventors: Hsich Gary , Kenney Kimbra, Gibbs Clarence J., and Harrington Michael G.  “Method of detecting transmissible spongiform encephalopathies.”  Patent for the detection of 14-3-3 proteins in the cerebrospinal fluid as a diagnostic tool in Creutzfeldt-Jakob disease.

Treatment & Services

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 8/12/2013, Dr. Hsich has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Hsich receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • National Institutes of Health (NIH)

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site